WAVE Life Sciences (FRA:1U5) Short Interest


FRA:1U5 WAVE Life Sciences Ltd FRA:1U5
59 GF Score
Price €4.72
GF Value €3.58
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is WAVE Life Sciences Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:1U5 vs AVLN, COAG, MPLT: Short Interest Comparison

For the Biotechnology subindustry, WAVE Life Sciences's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WAVE Life Sciences Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WAVE Life Sciences's Short Interest distribution charts can be found below:

* The bar in red indicates where WAVE Life Sciences's Short Interest falls into.


FRA:1U5
59GF Score
WAVE Life Sciences Ltd FRA:1U5
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is WAVE Life Sciences (FRA:1U5) Overvalued in 2026?

Based on GuruFocus' analysis, WAVE Life Sciences stock appears to be overvalued. The current stock price of €4.72 is trading 31.8% above its estimated GF Value™ of €3.58. GuruFocus considers WAVE Life Sciences to be Modestly Overvalued.

Key valuation signals for FRA:1U5:

  • Short Interest:
  • GF Value™: €3.58 vs. price of €4.72 (31.8% above fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the FRA:1U5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

WAVE Life Sciences Business Description

Other Exchanges WVE:USA1U5:Germany
Address 7 Straits View No. 12-00, Marina One East Tower, Singapore, SGP, 018936
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
59GF Score

Get the complete analysis for FRA:1U5

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.72
Price
€3.58
GF Value